NOV News
NOV Inc.
$19.27
-$1.28(-6.23%)
--
Overall
--
Value
--
Tech
--
Quality
Market Cap
--
Volume
10.02M
52W Range
$12.64 - $21.93
Target Price
--
NOV news: the latest NOV Inc. headlines, press releases and market updates, newest first.
Latest NOV News
- Novartis AG (NOVN) Gets a Buy from J.P. MorganTipRanks Auto-Generated Intelligence Newsdesk · Oct 29, 2026
- Analysts’ Opinions Are Mixed on These Energy Stocks: Range Resources (RRC) and NOV (NOV)TipRanks Newsroom · Oct 28, 2026
- Novo Nordisk (0QIU) Gets a Hold from J.P. MorganTipRanks Auto-Generated Intelligence Newsdesk · Oct 28, 2026
- Novan (NOVN) Gets a Hold from RBC CapitalTipRanks Auto-Generated Intelligence Newsdesk · Oct 28, 2026
- Piper Sandler Sticks to Its Hold Rating for NOV (NOV)TipRanks Auto-Generated Intelligence Newsdesk · Oct 28, 2026
- Citi Reaffirms Their Buy Rating on Novartis AG (NOVN)TipRanks Auto-Generated Intelligence Newsdesk · Oct 28, 2026
- Novartis AG (NOVN) Receives a Hold from JefferiesTipRanks Auto-Generated Intelligence Newsdesk · Oct 27, 2026
- Novo Nordisk Details Progress in DKK 15 Billion Share Buyback ProgrammeTipRanks Auto-Generated Newsdesk · Oct 26, 2026
- UBS Reaffirms Their Hold Rating on Novartis AG (NOVN)TipRanks Auto-Generated Intelligence Newsdesk · Oct 26, 2026
- Novartis AG (NOVN) Gets a Hold from BarclaysTipRanks Auto-Generated Intelligence Newsdesk · Oct 26, 2026
- Novatti Options Lapse Clarifies Future Capital StructureTipRanks Australian Auto-Generated Newsdesk · Oct 26, 2026
- Novatti Seeks ASX Quotation for Nearly 6 Million New SharesTipRanks Australian Auto-Generated Newsdesk · Oct 26, 2026
- Big Pharma’s Obesity Shopping Spree Is Moving Beyond GLP-1s. Palatin May Fit the Pattern (NASDAQ: PTN)Newswire TipRanks · Oct 21, 2026
- Novartis AG (NOVN) Gets a Hold from RBC CapitalTipRanks Auto-Generated Intelligence Newsdesk · Oct 21, 2026
- UBS Keeps Their Hold Rating on Novartis AG (NOVN)TipRanks Auto-Generated Intelligence Newsdesk · Oct 20, 2026
- UBS Keeps Their Hold Rating on Novartis AG (NOVN)TipRanks Auto-Generated Intelligence Newsdesk · Oct 20, 2026
- NOV (NOV) Receives a Rating Update from a Top AnalystTipRanks Auto-Generated Intelligence Newsdesk · Oct 20, 2026
- Novo Nordisk Expands 2026 Share Buyback, Lifting Treasury Stake to 1.2%TipRanks Auto-Generated Newsdesk · Oct 19, 2026
- Novo Nordisk Details Progress in DKK 15 Billion Share Buyback ProgrammeTipRanks Auto-Generated Newsdesk · Oct 13, 2026
- Barclays Keeps Their Hold Rating on Novartis AG (NOVN)TipRanks Auto-Generated Intelligence Newsdesk · Oct 13, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NOV | $19.27 | -6.2% | 10.02M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |